PTAB Finds Favor In Court; Novartis Is Latest To Strike Out In Challenge
Federal Circuit affirms US Patent Trial and Appeal Board decision against Gilenya composition patent a week after upholding board decision on Exelon Patch patents; court has reviewed 200 PTAB decisions and affirmed 158 of them.